Business
Curis Announces Date for the 2nd Symposium on IRAK4 in Cancer
Symposium hosted by Guillermo Garcia-Manero, M.D. and Eric Winer, M.D. Academics and industry professionals will gather virtually on September 22, 2023
About this update from Curis, Inc.
[{"type":"text","content":"Symposium hosted by Guillermo Garcia-Manero, M.D. and Eric Winer, M.D.\nAcademics and industry professionals will gather virtually on September 22, 2023\nLEXINGTON, Mass., Sept. 12, 2023 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib, an orally available, small molecule IRAK4 inhibitor for the treatment of hematologic malignancies, today announced the 2nd Symposium on IRAK4 in Cancer taking place virtually on September 22, 9:00am-1:00pm ET.\n\n \n \n \n \n \n \n\n \nHosted by Dr. Guillermo Garcia-Manero and Dr. Eric Winer, this symposium will focus on IRAK4, a key protein in the innate immune response and an emerging target in the treatment of hematologic malignancies and solid tumors. Experts across academia and industry will discuss IRAK4's biological and immunological roles as well as the promising role of targeting IRAK4 in cancer therapeutics.\n\"Following the success of last year's symposium on IRAK4 in cancer, Curis is pleased to continue its sponsorship of the Annual IRAK4 Symposium,\" said James Dentzer, President, and Chief Executive Officer of Curis. \"As a leader in IRAK4 inhibition in oncology with emavusertib, we are honored to provide a forum for discussing the biology of the IRAK4 pathway and IRAK4 inhibition in the research and development of therapies to benefit patients living with cancer.\"\nSymposium hosts:\nGuillermo Garcia-Manero, M.D. - Symposium Co-Chair - Professor, Department of Leukemia; Chief, Section of Myelodysplastic Syndromes and Deputy Chair, Translational Research, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer CenterEric Winer, M.D. – Symposium Co-Chair – Clinical Director, Adult Leukemia Institute Physician, Dana-Farber Cancer Institute; Assistant Professor of Medicine, Harvard Medical SchoolJoining our hosts will be the following speakers and participants:\nOmar Abdel-Wahab, M.D. - Edward P. Evans Chair in MDS, Director, Memorial Sloan Kettering Cancer Center (MSK) for Hematologic Malignancies; Member, Human Oncology and Pathogenesis Program & Leukemia ServiceClaudio Cerchione, M.D., Ph.D. - Hematologist, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCSBentley Doonan, M.D., M.S. - Assistant Professor, Division of Hematology & Oncology, University of Fl...